relationship between anti-mullerian hormone and assisted reproductive technique outcome in patients with polycystic ovary syndrome

Authors

marzieh agha hosseini

ashraf aleyasin

atossa mahdavi

sara mokhtar

abstract

background: anti-mullerian hormone (amh) levels may represent the ovarian follicular pool and could be a useful marker of ovarian reserve. the clinical application of amh measurement has been proposed in the prediction of quantitative and qualitative aspects in assisted reproductive technologies. objective: this study aimed to assess the relationship between the serum levels of amh and results of assisted reproductive technique (art) outcome in polycystic ovary syndrome (pcos) patients versus control group. materials and methods: this cohort study was conducted on 61 (pcos) patients and 28 patients without pcos (controls) candidates for assisted reproductive technique. serum levels of amh were measured on the 3rd day of menstrual cycle and all the patients underwent controlled ovarian hyper stimulation and art. the relationship between amh serum level with retrieved oocytes, mature oocytes and pregnancy rate were assessed. results: there was significant correlation between the amh level with number of total retrieved oocytes and mature oocytes in patients with pcos and controls (p=0.001). in pcos and control groups amh level in pregnant patients was higher, but it was not statistically significant (p=0.65, p=0.46, respectively). the major outcome of the study (pregnancy) did not differ significantly between two groups. conclusion: this study revealed that amh level was higher in pregnant patients undergoing art; but amh may not be an accurate predictor for pregnancy in pcos patients.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Relationship between anti-mullerian hormone and assisted reproductive technique outcome in patients with polycystic ovary syndrome

Background: Anti-mullerian hormone (AMH) levels may represent the ovarian follicular pool and could be a useful marker of ovarian reserve. The clinical application of AMH measurement has been proposed in the prediction of quantitative and qualitative aspects in assisted reproductive technologies. Objective: This study aimed to assess the relationship between the serum levels of AMH and results ...

full text

Relationship between Serum Levels of Anti-Mullerian Hormone, Adiponectin and Oxidative Stress Markers in Patients with Polycystic Ovary Syndrome

Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. Anti-Mullerian hormone (AMH) is a valid indicator of ovarian function and is used for PCOS diagnosis. Some studies have shown that adipokines affect the synthesis of AMH, and therefore they are somehow related in function. The aim of the present study was to determine the relationshi...

full text

P-85: Effect of Metformin on Anti-Mullerian Hormone (AMH) Level in Women with Infertility and Polycystic Ovary Syndrome

Background Women with PCOS have increased AMH levels due to accumulated preantral and small antral in follicles. Ovulation improvement following decrease in levels of AMH could accure in these patients. The purpose of this study was to evaluate the effect of metformin on anti-Mullerian hormone levels in women with polycystic ovary syndrome and infertility MaterialsAndMethods This randomized cli...

full text

Comparison of In Vitro Fertilization Cycle Outcome between Patients with Polycystic Ovary Syndrome and Tubal Factor

a:4:{s:10:"Background";s:381:"Infertility with an incidence of about 15% has been considered one of the major burdens on the community and has even been a threat to the continuity of the family life. One of the most prevalent causes of women infertility is ovarian causes particularly PCOS. The objective of this study was to determine the outcome of IVF & ET in women with PCOS in comparison with...

full text

The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.

STUDY QUESTION What is the relationship of serum anti-Mullerian hormone (AMH) with polycystic ovarian morphology (PCOM) and polycystic ovary syndrome (PCOS)? SUMMARY ANSWER Serum AMH concentrations are capable of differentiating between normal ovaries, PCOM and PCOS. WHAT IS KNOWN ALREADY Serum AMH levels are high in PCOS reflecting the number of small antral follicles and an intrinsic defe...

full text

The relationship between Anti-Müllerian hormone and other reproductive parameters in normal women and in women with polycystic ovary syndrome

OBJECTIVE To correlate Anti-Müllerian hormone (AMH) levels with years since menarche as well as to investigate the AMH relationship with ovarian morphology and levels of androgens in healthy normo- ovulatory women and in women with polycystic ovary syndrome (PCOS). DESIGN Prospective clinical study. SETTING University Hospital of Alexandroupolis, Lito Maternity Hospital. PATIENTS Forty tw...

full text

My Resources

Save resource for easier access later


Journal title:
international journal of reproductive biomedicine

جلد ۸، شماره ۴، صفحات ۱۶۱-۰

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023